We are live on ! Find out more
RLAY icon

Relay Therapeutics
RLAY

137 hedge funds and large institutions have $2.96B invested in Relay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

150% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 26

19% more funds holding

Funds holding: 115 → 137 (+22)

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

0% more call options, than puts

Call options by funds: $17K | Put options by funds: $17K

2.34% less ownership

Funds ownership: 97.46% → 95.12% (-2.3%)

19% less capital invested

Capital invested by funds: $3.64B → $2.96B (-$685M)

Holders
137
Holders Change
+22
Holders Change %
+19.13%
% of All Funds
2.41%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.23%
New
28
Increased
65
Reduced
26
Closed
6
Calls
$17K
Puts
$17K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$101M
2
DCM
Driehaus Capital Management
Illinois
+$62.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.3M
4
DGM
Darwin Global Management
Jersey
+$34M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$31.7M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$439M
2
TGI
TRV GP IV
Massachusetts
-$117M
3
CC
Casdin Capital
New York
-$18.8M
4
PA
Perceptive Advisors
New York
-$13.5M
5
AI
Alphabet Inc
California
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
JCM
126
Jacobi Capital Management
Pennsylvania
$29K +$33.2K +765 +1,109%
Macquarie Group
127
Macquarie Group
Australia
$19K -$11.2K -257 -32%
VFA
128
Valeo Financial Advisors
Indiana
$7K -$304 -7 -3%
Daiwa Securities Group
129
Daiwa Securities Group
Japan
$6K – – –
Fifth Third Bancorp
130
Fifth Third Bancorp
Ohio
$3K +$4.34K +100 New
YAL
131
Your Advocates Ltd
Texas
$3K +$4.34K +100 New
TWA
132
TCI Wealth Advisors
Arizona
$2K +$2.13K +49 New
TFO
133
Tarbox Family Office
California
$1K +$781 +18 New
SL
134
Savior LLC
Massachusetts
$1K +$868 +20 +100%
AIG
135
American International Group
New York
$924 +$348K +8,016 +43%
Nisa Investment Advisors
136
Nisa Investment Advisors
Missouri
$161 – – –
TGI
137
TRV GP III
Massachusetts
– -$439M -10,551,115 Closed
TGI
138
TRV GP IV
Massachusetts
– -$117M -2,811,197 Closed
MCM
139
Moore Capital Management
New York
– -$5.41M -130,162 Closed
Tudor Investment Corp
140
Tudor Investment Corp
Connecticut
– -$1.8M -43,286 Closed
APM
141
Avidity Partners Management
Texas
– -$1.25M -30,000 Closed
JG
142
Jefferies Group
New York
– -$416K -10,000 Closed
CS
143
Candriam SCA
Luxembourg
– +$477 +11 New
2 3 4 5
6

RLAY Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q1 2021, worth a combined $2.96B — down 19% from $3.64B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RLAY positions and 6 closed out — a net gain of 22 holders — while 65 added to existing stakes and 26 trimmed.

The largest buyer was Vanguard Group, adding an estimated $101M. The largest seller was TRV GP III, exiting entirely with an estimated $439M sold.

  • 137 institutional investors held Relay Therapeutics (RLAY) as of Q1 2021, up from 115 in Q4 2020.
  • Funds reported $2.96B of Relay Therapeutics stock for Q1 2021, down 19% quarter-over-quarter.
  • 28 funds opened new Relay Therapeutics positions in Q1 2021 and 6 closed out, a net change of +22 holders.
  • The largest Relay Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $101M added.
  • The largest Relay Therapeutics seller in Q1 2021 was TRV GP III, an estimated $439M sold.

Based on aggregated 13F filings for Q1 2021.